Determination of Serum Vascular Endothelial Growth Factor Levels in Attention Deficit Hyperactivity Disorder: A Case Control Study
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective: The effect of vascular endothelial growth factor (VEGF) on neuronal development is known, but its relationship with attention deficit hyperactivity disorder (ADHD), a neurodevelopmental disorder, has not yet been fully elucidated. To our knowledge, this is the first human study investigating serum VEGF levels in ADHD patients. In this study, it has been aimed to compare serum VEGF levels between a healthy control group and in ADHD patients to help determine the association between serum VEGF levels and ADHD. Methods: This study sample included forty-four patients diagnosed with ADHD and 43 healthy volunteer controls between 7 to 14 years old. Blood samples were taken from patients and the healthy control group to assess their serum VEGF levels. VEGF levels were calculated by subjecting the optical densities of the samples to concentrations of known standards as provided in the ELISA kit and then performing a regression correlation analysis. Results: The mean VEGF level of the children was 333.6 ± 209.8 in the ADHD group and 341.3 ± 201.8 in the control group. There were no statistically significant differences in serum VEGF levels between the ADHD and control groups (U = 926.000, z = −0.170, p = 0.865). Conclusion: There was no significant difference in serum VEGF levels for untreated ADHD cases and a healthy control group. This is the first human study investigating serum VEGF levels in ADHD patients, so there is a need to replicate these findings.
Abstract
Objective: The effect of vascular endothelial growth factor (VEGF) on neuronal development is known, but its relationship with attention deficit hyperactivity disorder (ADHD), a neurodevelopmental disorder, has not yet been fully elucidated. To our knowledge, this is the first human study investigating serum VEGF levels in ADHD patients. In this study, it has been aimed to compare serum VEGF levels between a healthy control group and in ADHD patients to help determine the association between serum VEGF levels and ADHD. Methods: This study sample included forty-four patients diagnosed with ADHD and 43 healthy volunteer controls between 7 to 14 years old. Blood samples were taken from patients and the healthy control group to assess their serum VEGF levels. VEGF levels were calculated by subjecting the optical densities of the samples to concentrations of known standards as provided in the ELISA kit and then performing a regression correlation analysis. Results: The mean VEGF level of the children was 333.6 ± 209.8 in the ADHD group and 341.3 ± 201.8 in the control group. There were no statistically significant differences in serum VEGF levels between the ADHD and control groups (U = 926.000, z = −0.170, p = 0.865). Conclusion: There was no significant difference in serum VEGF levels for untreated ADHD cases and a healthy control group. This is the first human study investigating serum VEGF levels in ADHD patients, so there is a need to replicate these findings.
참고문헌 (32)
- Polanczyk G, "The worldwide prevalence of ADHD : a systematic review and metaregression analysis", Am J Psychiatry, 164, pp.942~948 (2007)
- Aguiar A, "Attention deficit", hyperactivity disorder : a focused overview for children’s environmental health researchers, 2010, pp.118, 1646~1653
- Tsai SJ, "Role of neurotrophic factors in attention deficit hyperactivity disorder", Cytokine Growth Factor Rev, 34, pp.35~41 (2017)
- Syed Z, "An investigation of the neurotrophic factor genes GDNF, NGF, and NT3 in susceptibility to ADHD", Am J Med Genet B Neuropsychiatr Genet, 144B, pp.375~378 (2007)
- Galvez-Contreras AY, "Alterations of growth factors in autism and attention-deficit", hyperactivity disorder, 2017, pp.8, 126~
- Costales J, "The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders", Neurosci Biobehav Rev, 63, pp.207~222 (2016)
- Ribasés M, "Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit", hyperactivity disorder identifies association for 5HT2A, DDC and MAOB, 2009, pp.14, 71~85
- Galvez-Contreras AY, "Role of fibroblast growth factor receptors in astrocytic stem cells", Curr Signal Transduct Ther, 7, pp.81~86 (2012)
- Jesmin S, "Gonadal hormones and frontocortical expression of vascular endothelial growth factor in male stroke-prone, spontaneously hypertensive rats, a model for attention-deficit", hyperactivity disorder, 2004, pp.145, 4330~4343
- Virgintino D, "VEGF expression is developmentally regulated during human brain angiogenesis", Histochem Cell Biol, 119, pp.227~232 (2003)
- Haigh JJ, "Cortical and retinal defects caused by dosage-dependent reductions in VEGF-A paracrine signaling", Dev Biol, 262, pp.225~241 (2003)
- Skaper SD, "The biology of neurotrophins, signalling pathways, and functional peptide mimetics of neurotrophins and their receptors", CNS Neurol Disord Drug Targets, 7, pp.46~62 (2008)
- Kan KJ, "Genetic and environmental stability in attention problems across the lifespan : evidence from the Netherlands twin register", J Am Acad Child Adolesc Psychiatry, 52, pp.12~25 (2013)
- Castellanos FX, "Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit", hyperactivity disorder, 2002, pp.288, 1740~1748
- Liu DY, "The physiology of BDNF and its relationship with ADHD", Mol Neurobiol, 52, pp.1467~1476 (2015)
- Jesmin S, "Characterization of regional cerebral blood flow and expression of angiogenic growth factors in the frontal cortex of juvenile male SHRSP and SHR", Brain Res, 1030, pp.172~182 (2004)
- Oner O, "Regional cerebral blood flow in children with ADHD : changes with age", Brain Dev, 27, pp.279~285 (2005)
- Allred EN, "Systemic inflammation during the first postnatal month and the risk of attention deficit hyperactivity disorder characteristics among 10 year-old children born extremely preterm", J Neuroimmune Pharmacol, 12, pp.531~543 (2017)
- Clark-Raymond A, "Vascular endothelial growth factor : potential predictor of treatment response in major depression", World J Biol Psychiatry, 18, pp.575~585 (2017)
- Howell KR, "Vascular endothelial growth factor(VEGF)in neurodevelopmental disorders", Curr Behav Neurosci Rep, 4, pp.299~308 (2017)
- Newton SS, "Vascular growth factors in neuropsychiatry", Cell Mol Life Sci, 70, pp.1739~1752 (2013)
- Masi A, "Cytokine levels and associations with symptom severity in male and female children with autism spectrum disorder", Mol Autism, 8, pp.63~ (2017)
- Zakareia FA, "Study of dual angiogenic", neurogenic growth factors among Saudi autistic children and their correlation with the severity of this disorder, 2012, pp.17, 213~218
- Emanuele E, "Serum levels of vascular endothelial growth factor and its receptors in patients with severe autism", Clin Biochem, 43, pp.317~319 (2010)
- Lee BH, "Alterations in plasma vascular endothelial growth factor levels in patients with schizophrenia before and after treatment", Psychiatry Res, 228, pp.95~99 (2015)
- Pillai A, "Association of serum VEGF levels with prefrontal cortex volume in schizophrenia", Mol Psychiatry, 21, pp.686~692 (2016)
- Fulzele S, "Decreased VEGF mRNA expression in the dorsolateral prefrontal cortex of schizophrenia subjects", Schizophr Res, 115, pp.372~373 (2009)
- Nguyen TT, "Abnormal levels of vascular endothelial biomarkers in schizophrenia", Eur Arch Psychiatry Clin Neurosci, 268, pp.849~860 (2018)
- Misiak B, "Vascular endothelial growth factor in patients with schizophrenia : a systematic review and meta-analysis", Prog Neuropsychopharmacol Biol Psychiatry, 86, pp.24~29 (2018)
- Kaufman J, "Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version(K-SADS-PL) : initial reliability and validity data", J Am Acad Child Adolesc Psychiatry, 36, pp.980~988 (1997)
- Gökler B, "Reliability and validity of schedule for affective disorders and schizophrenia for school age children--present and lifetime version--Turkish version(K-SADS-PL-T)", Turk J Child Adolesc Ment Health, 11, pp.109~116 (2004)[DOI]
- Sontag TA, "Animal models of attention deficit", hyperactivity disorder(ADHD) : a critical review, 2010, pp.2, 1~20